Ya-Hsuan Chang, Tzu-Chan Hong, Kuen-Tyng Lin,…,Hsuan-Yu Chen*, Sung-Liang Yu, Ming-Shiang Wu, Yu-Ju Chen, Integrative proteogenomics maps multifactorial aetiology, progression and therapeutic vulnerabilities in gastric cancer, Gut, doi: 10.1136/gutjnl-2025-337247 (IF: 26.2; Ranking: 4/148, 2.7%) Corresponding author
Shankha Satpathy, Natalie M. Clark, Yi-Ju Chen,…,Hsuan-Yu Chen*, Alexey I. Nesvizhskii, Steven A. Carr, D. R. Mani, Marcin P. Cieslik, Yu-Ju Chen, Michael A. Gillette, 2025, Integrative Analysis of Lung Adenocarcinoma Across Diverse Ethnicities and Exposures, Cancer Cell, 43: 1731-1757 (IF: 44.5; Ranking: 5/326, 1.5%) Corresponding author
Shih-Pin Chen, Ya-Hsuan Chang, Yen-Feng Wang, Hsuan-Yu Chen*, Shuu-Jiun Wang, 2025, Composite microRNA-genetic risk score model links to migraine and implicates its pathogenesis, Brain, 148: 2178-2188 (IF: 11.7; Ranking: 5/285, 1.8%) Corresponding author
Yi-Ju Chen, Theodoros I. Roumeliotis, Ya-Hsuan Chang,…,Hsuan-Yu Chen*, Pan-Chyr Yang, Yu-Ju Chen, 2020, Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression, Cell, 182, 226-244. (IF: 42.5; Ranking: 2/320, 0.6%) Corresponding author
Poyin Huang, Yuan-Han Yang, Ya-Hsuan Chang, Shu-Ling Chang, Mei-Chuan Chou, Chiou-Lian Lai, Ching-Kuan Liu, Hsuan-Yu Chen*, 2020, Association of early-onset Alzheimers disease with germline-generated high affinity self-antigen load, Translational Psychiatry, 10, 146. (IF: 6.2; Ranking: 21/288, 7.3%) Corresponding author
Chen HY, Yu SL, Ho BC,…,Chang GC, Yang PC, Li KC, 2015, R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability., Journal of Clinical Oncology, 33, 2303-2310. (IF: 41.9; Ranking: 6/326, 1.8%)
Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC, 2007, A five-gene signature and clinical outcome in non-small-cell lung cancer., New England Journal of Medicine, 356, 11-20. (IF: 78.5; Ranking: 2/332, 0.6%)
